Cardiovascular

Shop Top Sellers

ENDS SOON

Shop Now
00
:
00
:
00
:
00
Days
Hours
Mins
Secs

Sort by

Wholesaler Options
Wholesaler Options
Wholesaler Options
Wholesaler Options
Wholesaler Options
  • Product label: Back in Stock
Ezetimibe Ezetimibe
Options Wholesaler
Wholesaler Options
Wholesaler Options
Wholesaler Options
Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
More info
X
Indication:

Rheumatoid Arthritis,Yuflyma is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. This includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate.
Yuflyma can be used alone or in combination with methotrexate.,Juvenile Idiopathic Arthritis,Polyarticular Juvenile Idiopathic Arthritis,Yuflyma in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response to one or more disease modifying anti-rheumatic drugs (DMARDs). Yuflyma can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.,Enthesitis-Related Arthritis,Yuflyma is indicated for the treatment of enthesitis-related arthritis in children, who have had an inadequate response to, or who are intolerant to, conventional therapy.,Psoriatic Arthritis,Yuflyma is indicated for the treatment of signs and symptoms, as well as inhibiting the progression of structural damage, of moderate to severely active psoriatic arthritis in adult patients where response to previous DMARDs has been inadequate.,Ankylosing Spondylitis,Yuflyma is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.
Crohn's Disease in Adults and Children (6 years and older),Yuflyma is indicated for the treatment of moderate to severe Crohn's disease, to reduce the signs and symptoms of the disease and to induce and maintain clinical remission in patients;,· who have had an inadequate response to conventional therapies or,,· who have lost response to or are intolerant to infliximab,Ulcerative colitis,Yuflyma is indicated for the treatment of moderate to severe ulcerative colitis in adult patients who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies. Patients should show a clinical response within 8 weeks of treatment to continue treatment beyond that time. (see 5.1 PHARMACODYNAMIC PROPERTIES - CLINICAL TRIALS).,Psoriasis in Adults and Children,Yuflyma is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.,Yuflyma is indicated for the treatment of severe chronic plaque psoriasis in children and adolescent patients from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapy.,Hidradenitis Suppurativa in Adults and Adolescents (from 12 years of age),Yuflyma is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in patients with an inadequate response to conventional systemic hidradenitis suppurativa therapy.,Uveitis,Yuflyma is indicated for the treatment of non-infectious intermediate, posterior and pan-uveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid sparing, or in whom corticosteroid treatment is inappropriate.

Generic Name: Adalimumab

Strength:40mg/0.4ml

Dosage:

Shelflife Months: 36

Pack Size:

Tablet Description:

Segment :A

Innovator:

PBSListed:Yes

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: Adalimumab 40mg

More info
X
Indication:

Hypertension
PHARMACOR AMLODIPINE is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of PHARMACOR AMLODIPINE, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.
Angina
PHARMACOR AMLODIPINE is indicated for the first line treatment of chronic stable angina. PHARMACOR AMLODIPINE may be used alone, as monotherapy or in combination with other antianginal drugs.

Generic Name: Amlodipine

Strength:5mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:White to off-white, octagonal, flat faced, bevelled edged scored tablet debossed with "210" and "5" on one side and plain on other side

Segment :B

Innovator:Norvasc ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: amlodipine besilate 6.93mg
Equivalent: amlodipine 5mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-02327-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-02330-1

More info
X
Indication:

Atorvastatin is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia.
Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated.
Atorvastatin is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD (see section 5.1, Pharmacodynamic properties, Prevention of Cardiovascular Disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke.
These effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

Generic Name: Atorvastatin

Strength:10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White elliptical shaped, film coated tablets, debossed with "10" on one side and "ATS" on other side

Segment :B

Innovator:Lipitor®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: atorvastatin calcium trihydrate 10.845mg
Equivalent: atorvastatin 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-02356-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-02369-1

More info
X
Indication:


Cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: Acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis.
Acute exacerbations of chronic bronchitis, or acute bronchitis.
Skin and skin structure infections for example, furunculosis, pyoderma and impetigo.
Acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

Generic Name: Cefuroxime axetil

Strength:250mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 14

Tablet Description:Blue color capsule shaped biconvex film coated tablets with '204' debossed on one side and plain on the other side

Segment :A

Innovator:Pharmacor Cefuroxime®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: cefuroxime axetil 300.715mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-01527-1&d=20241003172310101

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-01526-1&d=20241003172310101

More info
X
Indication:


Generic Name: Cephalexin

Strength:500mg

Dosage:Caps

Shelflife Months: 36

Pack Size: 20

Tablet Description:

Segment :B

Innovator:Keflex®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:

Active Ingredients:

More info
X
Indication:

Cinacalcet may be used to treat the biochemical manifestations of secondary hyperparathyroidism in patients with end stage renal disease, receiving dialysis. Cinacalcet should be used as adjunctive therapy. ,Cinacalcet is indicated for the treatment of hypercalcaemia in patients with parathyroid carcinoma. ,Cinacalcet may be used to treat the biochemical manifestations of primary hyperparathyroidism in patients for whom parathyroidectomy is not a treatment option.

Generic Name: Cinacalcet

Strength:30mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 28

Tablet Description:Light green colored, oval shaped, film coated tablets debossed with 'A33' on one side
and '30' on other side

Segment :A

Innovator:Sensipar®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: cinacalcet hydrochloride 66mg Equivalent: cinacalcet 60mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-PI-01248-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-CMI-01250-1

More info
X
Indication:

Clobazam is indicated in Adults -Short term use (up to one month) for the symptomatic management of acute anxiety and sleep disturbances associated with anxiety and in Children (4 years of age and over) - As adjunctive therapy in patients with partial refractory and Lennox-Gastaut epilepsy types who are not adequately stabilized with their current anticonvulsant therapy.

Generic Name: Clobazam

Strength:10mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:White to off white oval shaped uncoated tablets with a functional score on one side and "C" and "10" debossed on other side

Segment :B

Innovator:Frisium®

PBSListed:No

RPBSlisted:No

Schedule: S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: clobazam 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01888-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01886-1

More info
X
Indication:

Relief of pain in acute gout. Colchicine should not be used unless NSAIDS are contraindicated, or have been used and found to lack analgesic efficacy or to have unacceptable side effects in the individual patient. Colchicine is not an analgesic and does not provide relief from other types of pain.

Generic Name: Colchicine

Strength:0.5mg

Dosage:Tabs

Shelflife Months: 31

Pack Size: 30

Tablet Description:Round, off white coloured biconvex, uncoated tablets embossed “C5” on one upper side and plain on the bottom face

Segment :A

Innovator:Colgout®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: colchicine 500 microgram

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01410-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01413-1

More info
X
Indication:

Dabigatran is indicated for Prevention of venous thromboembolic events in adult patients who have undergone major orthopaedic surgery of the lower limb (elective total hip or knee replacement). Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE in adults.

Generic Name: Dabigatran

Strength:110mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 60

Tablet Description:White to pale yellow pellets in HPMC capsule size "0EL" Lt blue opq body & Lt cream opq cap imprinted "150" on body & "DAB" on cap in black ink

Segment :A

Innovator:Pradaxa ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: dabigatran etexilate mesilate 172.95mg
Equivalent: dabigatran etexilate 150mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-02037-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-CMI-02036-1

More info
X
Indication:

The treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. Deferasirox is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective.,Deferasirox is also indicated for the treatment of chronic iron overload in patients with nontransfusion-dependent thalassemia syndromes aged 10 years and older.

Generic Name: Deferasirox

Strength:90mg

Dosage:FC Tab

Shelflife Months: 36

Pack Size: 30

Tablet Description:Light blue colour, film coated oval shaped biconvex tablets, debossed with 'DFX' on the one side and '90' on other side

Segment :B

Innovator:Jadenu®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: deferasirox 90mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01406-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01408-1

More info
X
Indication:


Generic Name: DMF

Strength:120g

Dosage:Caps

Shelflife Months: 30

Pack Size: 14

Tablet Description:

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S4

Storage Conditions:

Active Ingredients:

More info
X
Indication:

DULOXETINE is indicated for the treatment of major depressive disorder (MDD).,DULOXETINE is indicated for the treatment of diabetic peripheral neuropathic pain (DPNP).,DULOXETINE is indicated for the treatment of generalised anxiety disorder (GAD)

Generic Name: Duloxetine

Strength:30mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 28

Tablet Description:Opaque blue colour cap and opaque white colour body, imprinted “Dulox” on cap with white ink and “30 mg” on body with black ink

Segment :B

Innovator:Cymbalta®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: duloxetine hydrochloride 33.66mg

More info
X
Indication:

Everolimus is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see section 4.4 Special warnings and precautions for use).

Generic Name: Everolimus

Strength:0.25mg

Dosage:Tab

Shelflife Months: 24

Pack Size: 60

Tablet Description:White to off white, round shaped tablets debossed with "EVR" on one side and "25" on other side

Segment :A

Innovator:Certican®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: everolimus 0.25mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01468-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01469-1

More info
X
Indication:

Adults (≥18 years),Prevention of Cardiovascular Disease,Ezetimibe and Simvastatin Tablets is indicated in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS) taking their maximum tolerated dose of simvastatin and in need of additional lowering of LDL-C in the expectation of a modest further reduction in the risk of cardiovascular events following at least one year of therapy.,Primary Hypercholesterolaemia,Ezetimibe and Simvastatin Tablets is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate:,· Patients not appropriately controlled with a statin or ezetimibe alone.,· Patients already treated with a statin and ezetimibe.,Homozygous Familial Hypercholesterolaemia (HoFH),Ezetimibe and Simvastatin Tablets is indicated in patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).,Children and Adolescents 10-17 years,(pubertal status: boys Tanner Stage II and above and girls who are at least one year post-menarche),Heterozygous Familial Hypercholesterolaemia (HeFH),Ezetimibe and Simvastatin Tablets is indicated as adjunctive therapy to diet in adolescent patients (10-17 years old) with heterozygous familial hypercholesterolaemia where use of a combination product is appropriate:,· Patients not appropriately controlled with a statin or ezetimibe alone.,· Patients already treated with a statin and ezetimibe.,Homozygous Familial Hypercholesterolaemia (HoFH),Ezetimibe and Simvastatin Tablets is indicated in adolescent patients (10-17 years old) with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).

Generic Name: Ezetimibe ; simvastatin

Strength:10mg;10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White to off white, capsule shaped tablets debossed with "A029" on one side and plain on other side

Segment :B

Innovator:Vytorin®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ezetimibe 10mg simvastatin 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-PI-01201-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-CMI-01203-1

More info
X
Indication:

Primary HypercholesterolaemiaPHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:,· not appropriately controlled with rosuvastatin or ezetimibe alone; or,· already treated with rosuvastatin and ezetimibe,Homozygous Familial Hypercholesterolaemia (HoFH),PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).

Generic Name: Ezetimibe; Rosuvastatin

Strength:

Dosage:

Shelflife Months:

Pack Size:

Tablet Description:

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ezetimibe 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-PI-01230-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-CMI-01229-1

More info
X
Indication:

Pharmacor Finasteride 1 is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. Efficacy has not been demonstrated in men over the age of 41 years. Pharmacor Finasteride 1 is not indicated for use in women (see Use in Pregnancy and Clinical Studies) or children.

Generic Name: Finasteride

Strength:1mg

Dosage:Tabs

Shelflife Months: 48

Pack Size: 28

Tablet Description:Reddish brown, 7 mm, round, biconvex, film-coated tablet, marked 'F1' on one side and plain on the other

Segment :A

Innovator:Propecia®

PBSListed:No

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: finasteride 1mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-02569-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-02570-1

Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
More info
X
Indication:

Topical treatment of fungal skin infections such as tinea or ringworm (eg. tinea pedis, tinea corporis or tinea cruris); Pityriasis versicolor; and candidal,infections (eg. external genital thrush, thrush-infected nappy rash).

Generic Name: Clotrimazole

Strength:0.01

Dosage:Tube

Shelflife Months: 36

Pack Size: 1

Tablet Description:White, smooth semi-solid cream

Segment :B

Innovator:Canesten Cream®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: clotrimazole 1%w/w

More info
X
Indication:

Maintain/support bone health
Aids/assists healthy bone development/growth/building
Maintain/support bone mass/density/integrity
Maintain/support bone strength
A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate

Generic Name: Cal-Care

Strength:600mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 120

Tablet Description:Tablet, film coated

Segment :B

Innovator:Caltrate®

PBSListed:No

RPBSlisted:Yes

Schedule:UNS

Storage Conditions:

Active Ingredients: calcium carbonate 1.5g

More info
X
Indication:

Provides relief from nasal congestion due to colds, influenza, allergies and sinusitis

Generic Name: Decongestant Nasal

Strength:500mcg/mL

Dosage:Spray

Shelflife Months: 30

Pack Size: 1

Tablet Description:A clear colourless liquid

Segment :B

Innovator:Drixine®

PBSListed:No

RPBSlisted:Yes

Schedule:S2

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: oxymetazoline hydrochloride 0.5 mg/ml

More info
X
Indication:

For the treatment of patients with known cardiovascular or cerebrovascular disease as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)

Generic Name: Aspirin

Strength:100mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 168

Tablet Description:Orange coloured circular, biconvex coated tablet having Heart shape embossed on one side and plain on other side

Segment :B

Innovator:Cartia®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: aspirin 100.008mg

X
Indication:

Helps enhance/promote bone health
Aids/assists healthy bone development/growth/building
A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life
Helps reduce occurrence of muscle cramp
Maintain/support muscle health during the day in adults

Generic Name: Cal + Vit D

Strength:600mg;1000IU

Dosage:Tabs

Shelflife Months: 24

Pack Size: 120

Tablet Description:White tablet, film coated

Segment :B

Innovator:Ostevit D + Calcium®

PBSListed:No

RPBSlisted:No

Schedule:UNS

Storage Conditions:

Active Ingredients:
calcium carbonate 1.5g
Equivalent: calcium 600mg
colecalciferol 1000 IU

More info
X
Indication:

Effective relief from persistent pain for up to 8 hours. Effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. Provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. Reduces fever.

Generic Name: Paracetamol

Strength:665mg

Dosage:MR Tabs

Shelflife Months: 48

Pack Size: 192

Tablet Description:White to off white beveled shaped, biconvex, film coated tablets plain on both sides

Segment :O

Innovator:Osteomol 665 Paracetamol ®

PBSListed:Yes

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 665mg

More info
X
Indication:

ALLERGIES: Treatment of allergic conditions including some allergic reactions to drugs, urticaria, contact dermatitis, and allergic reactions to insect bites and stings. ,UPPER RESPIRATORY TRACT: Relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis.,NAUSEA AND VOMITING: Antiemetic in vomiting of various causes, including post-operative vomiting, irradiation sickness, drug induced nausea, and motion sickness. ,SEDATION: For short term use on the advice of a doctor or pharmacist.

Generic Name: Promezine

Strength:10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 50

Tablet Description:Round, pale blue to blue, film coated tablet, plain on both sides.

Segment :B

Innovator:

PBSListed:

RPBSlisted:

Schedule:S3

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: promethazine hydrochloride 10mg

X
Indication:

Topical corticosteroid therapy for the temporary relief of symptoms of non-infected inflammatory conditions of the skin [e.g. minor skin irritations, itching and rashes due to eczema, dermatitis, contact dermatitis (such as rashes due to soap, detergent, cosmetics and jewellery), insect bites, itching of anal and genital areas, and sunburn]

Generic Name: Hydrocortic Clotrimazole

Strength:1%;1%

Dosage:Tube

Shelflife Months: 24

Pack Size: 1

Tablet Description:White soft cream

Segment :A

Innovator:Hydrozole®

PBSListed:

RPBSlisted:

Schedule:

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hydrocortisone acetate 10mg/g

More info
X
Indication:


Soothe skin
Maintain/support skin health Maintain/support skin integrity/structure

Generic Name: Skin Basics

Strength:100g

Dosage:Cream

Shelflife Months: 36

Pack Size: 1

Tablet Description: Cream

Segment :B

Innovator:Skin Basics®

PBSListed:No

RPBSlisted:No

Schedule:UNS

Storage Conditions:

Active Ingredients:
Castor Oil 100mg/g zinc oxide 75 mg/g

Warnings:'Contains peanuts/peanut products'

X
Indication:

For effective temporary relief of fever and pain associated with immunisation, earache, headache, symptoms of colds and flu.

Generic Name: Paracetamol

Strength:48mg/mL

Dosage:Liquid

Shelflife Months: 24

Pack Size: 1

Tablet Description:White to off white uniform suspension with characteristic flavour

Segment :B

Innovator:Panadol 5-12 ®

PBSListed:No

RPBSlisted:Yes

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 48mg/ml

X
Indication:

For the prevention of travel sickness

Generic Name: Travel-Ease

Strength:0.15mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pink colored, biplanar, round shaped, beveled edges uncoated tablets with break line on one side and plain on other side.

Segment :A

Innovator:

PBSListed:No

RPBSlisted:

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hyoscine hydrobromide 0.15mg

More info
X
Indication:

Pharmacor Sumatriptan is indicated for the acute relief of migraine attacks with or without aura.,There is no information available on the use of Sumatriptan tablets in the treatment of basilar or hemiplegic migraine

Generic Name: Sumatriptan

Strength:50mg

Dosage:Tabs

Shelflife Months:

Pack Size:

Tablet Description:Pink coloured, capsule shaped, biconvex film coated tablet plain on both sides

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: sumatriptan succinate 69.99mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-01148-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01298-1

More info
X
Indication:

Relief of symptoms associated with seasonal allergic rhinitis or urticaria in adults and children aged 12 years or older.

Generic Name: Fexit

Strength:180mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 10

Tablet Description:Peach coloured, caplet shaped, debossed as '180' on one side and plain on the other

Segment :B

Innovator:Telfast ®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: fexofenadine hydrochloride 180mg

More info
X
Indication:

Traditionally used in Western herbal medicine to decrease/reduce/relieve mild joint aches and pains

Generic Name: Relispray

Strength:95mg

Dosage:

Shelflife Months: 36 M

Pack Size: 1

Tablet Description:

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:

Storage Conditions:

Active Ingredients: camphor 100mg/g, Clove Leaf Oil 10 mg/g, Eucalyptus Oil 60 mg/g, menthol 40 mg/g, turpentine oil 100 mg/g, wintergreen oil 200 mg/g

Warnings:If symptoms persist consult your healthcare practitioner (or words to that effect). Keep out of reach of children (or words to that effect).

X
Indication:

Relief from the burning pain of cystitis. Urinary alkaliniser.

Generic Name: Cystitis Relief

Strength:4g 890mg;630mg;1.76g;720mg

Dosage:Sachet

Shelflife Months: 36

Pack Size: 28

Tablet Description:White coloured free flowing granules

Segment :C

Innovator:Ural ®

PBSListed:No

RPBSlisted:YEs

Schedule:UNS

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: citric acid 720mg
sodium bicarbonate 1.76g. sodium citrate 630mg tartaric acid 890mg

X
Indication:

For the prevention of travel sickness

Generic Name: Travel-Ease

Strength:0.3mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pink colored, biplanar, round shaped, beveled edges uncoated tablets with break line on one side and plain on other side.

Segment :A

Innovator:

PBSListed:No

RPBSlisted:

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hyoscine hydrobromide 0.3mg

Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
More info
X
Indication:

Rheumatoid Arthritis,Yuflyma is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. This includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate.
Yuflyma can be used alone or in combination with methotrexate.,Juvenile Idiopathic Arthritis,Polyarticular Juvenile Idiopathic Arthritis,Yuflyma in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response to one or more disease modifying anti-rheumatic drugs (DMARDs). Yuflyma can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.,Enthesitis-Related Arthritis,Yuflyma is indicated for the treatment of enthesitis-related arthritis in children, who have had an inadequate response to, or who are intolerant to, conventional therapy.,Psoriatic Arthritis,Yuflyma is indicated for the treatment of signs and symptoms, as well as inhibiting the progression of structural damage, of moderate to severely active psoriatic arthritis in adult patients where response to previous DMARDs has been inadequate.,Ankylosing Spondylitis,Yuflyma is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.
Crohn's Disease in Adults and Children (6 years and older),Yuflyma is indicated for the treatment of moderate to severe Crohn's disease, to reduce the signs and symptoms of the disease and to induce and maintain clinical remission in patients;,· who have had an inadequate response to conventional therapies or,,· who have lost response to or are intolerant to infliximab,Ulcerative colitis,Yuflyma is indicated for the treatment of moderate to severe ulcerative colitis in adult patients who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies. Patients should show a clinical response within 8 weeks of treatment to continue treatment beyond that time. (see 5.1 PHARMACODYNAMIC PROPERTIES - CLINICAL TRIALS).,Psoriasis in Adults and Children,Yuflyma is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.,Yuflyma is indicated for the treatment of severe chronic plaque psoriasis in children and adolescent patients from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapy.,Hidradenitis Suppurativa in Adults and Adolescents (from 12 years of age),Yuflyma is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in patients with an inadequate response to conventional systemic hidradenitis suppurativa therapy.,Uveitis,Yuflyma is indicated for the treatment of non-infectious intermediate, posterior and pan-uveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid sparing, or in whom corticosteroid treatment is inappropriate.

Generic Name: Adalimumab

Strength:40mg/0.4ml

Dosage:

Shelflife Months: 36

Pack Size:

Tablet Description:

Segment :A

Innovator:

PBSListed:Yes

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: Adalimumab 40mg

More info
X
Indication:


Cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: Acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis.
Acute exacerbations of chronic bronchitis, or acute bronchitis.
Skin and skin structure infections for example, furunculosis, pyoderma and impetigo.
Acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

Generic Name: Cefuroxime axetil

Strength:250mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 14

Tablet Description:Blue color capsule shaped biconvex film coated tablets with '204' debossed on one side and plain on the other side

Segment :A

Innovator:Pharmacor Cefuroxime®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: cefuroxime axetil 300.715mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-01527-1&d=20241003172310101

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-01526-1&d=20241003172310101

More info
X
Indication:

Pharmacor Finasteride 1 is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. Efficacy has not been demonstrated in men over the age of 41 years. Pharmacor Finasteride 1 is not indicated for use in women (see Use in Pregnancy and Clinical Studies) or children.

Generic Name: Finasteride

Strength:1mg

Dosage:Tabs

Shelflife Months: 48

Pack Size: 28

Tablet Description:Reddish brown, 7 mm, round, biconvex, film-coated tablet, marked 'F1' on one side and plain on the other

Segment :A

Innovator:Propecia®

PBSListed:No

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: finasteride 1mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-02569-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-02570-1

More info
X
Indication:

Relief of pain in acute gout. Colchicine should not be used unless NSAIDS are contraindicated, or have been used and found to lack analgesic efficacy or to have unacceptable side effects in the individual patient. Colchicine is not an analgesic and does not provide relief from other types of pain.

Generic Name: Colchicine

Strength:0.5mg

Dosage:Tabs

Shelflife Months: 31

Pack Size: 30

Tablet Description:Round, off white coloured biconvex, uncoated tablets embossed “C5” on one upper side and plain on the bottom face

Segment :A

Innovator:Colgout®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: colchicine 500 microgram

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01410-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01413-1

More info
X
Indication:

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. PHARMACOR METFORMIN XR 500, PHARMACOR METFORMIN XR 750 or PHARMACOR METFORMIN XR 1000 may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Generic Name: Metformin hydrochloride

Strength:500mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 120

Tablet Description:White to off white, oval shaped, biconvex tablets with MX debossed on one side and 500 on other side

Segment :A

Innovator:Diabex XR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: metformin hydrochloride 500mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-02436-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-02437-1

More info
X
Indication:

Lacosamide film-coated tablets are indicated as:
· monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. · add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. · add-on therapy in the treatment of primary generalised tonic-clonic seizures in
patients with idiopathic generalised epilepsy aged 4 years and older.

Generic Name: Lacosamide

Strength:50mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 14

Tablet Description:Pink, oval shaped, film coated tablets debossed with "LAC" on one side and "50" on other side.

Segment :A

Innovator:

PBSListed:Yes

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: lacosamide 50mg

More info
X
Indication:

Dabigatran is indicated for Prevention of venous thromboembolic events in adult patients who have undergone major orthopaedic surgery of the lower limb (elective total hip or knee replacement). Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE in adults.

Generic Name: Dabigatran

Strength:110mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 60

Tablet Description:White to pale yellow pellets in HPMC capsule size "0EL" Lt blue opq body & Lt cream opq cap imprinted "150" on body & "DAB" on cap in black ink

Segment :A

Innovator:Pradaxa ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: dabigatran etexilate mesilate 172.95mg
Equivalent: dabigatran etexilate 150mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-02037-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-CMI-02036-1

More info
X
Indication:

Cinacalcet may be used to treat the biochemical manifestations of secondary hyperparathyroidism in patients with end stage renal disease, receiving dialysis. Cinacalcet should be used as adjunctive therapy. ,Cinacalcet is indicated for the treatment of hypercalcaemia in patients with parathyroid carcinoma. ,Cinacalcet may be used to treat the biochemical manifestations of primary hyperparathyroidism in patients for whom parathyroidectomy is not a treatment option.

Generic Name: Cinacalcet

Strength:30mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 28

Tablet Description:Light green colored, oval shaped, film coated tablets debossed with 'A33' on one side
and '30' on other side

Segment :A

Innovator:Sensipar®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: cinacalcet hydrochloride 66mg Equivalent: cinacalcet 60mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-PI-01248-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-CMI-01250-1

X
Indication:

Topical corticosteroid therapy for the temporary relief of symptoms of non-infected inflammatory conditions of the skin [e.g. minor skin irritations, itching and rashes due to eczema, dermatitis, contact dermatitis (such as rashes due to soap, detergent, cosmetics and jewellery), insect bites, itching of anal and genital areas, and sunburn]

Generic Name: Hydrocortic Clotrimazole

Strength:1%;1%

Dosage:Tube

Shelflife Months: 24

Pack Size: 1

Tablet Description:White soft cream

Segment :A

Innovator:Hydrozole®

PBSListed:

RPBSlisted:

Schedule:

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hydrocortisone acetate 10mg/g

More info
X
Indication:

Primary HypercholesterolaemiaPHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:,· not appropriately controlled with rosuvastatin or ezetimibe alone; or,· already treated with rosuvastatin and ezetimibe,Homozygous Familial Hypercholesterolaemia (HoFH),PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).

Generic Name: Ezetimibe; Rosuvastatin

Strength:

Dosage:

Shelflife Months:

Pack Size:

Tablet Description:

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ezetimibe 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-PI-01230-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-CMI-01229-1

X
Indication:

For the prevention of travel sickness

Generic Name: Travel-Ease

Strength:0.15mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pink colored, biplanar, round shaped, beveled edges uncoated tablets with break line on one side and plain on other side.

Segment :A

Innovator:

PBSListed:No

RPBSlisted:

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hyoscine hydrobromide 0.15mg

More info
X
Indication:

Pharmacor Sumatriptan is indicated for the acute relief of migraine attacks with or without aura.,There is no information available on the use of Sumatriptan tablets in the treatment of basilar or hemiplegic migraine

Generic Name: Sumatriptan

Strength:50mg

Dosage:Tabs

Shelflife Months:

Pack Size:

Tablet Description:Pink coloured, capsule shaped, biconvex film coated tablet plain on both sides

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: sumatriptan succinate 69.99mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-01148-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01298-1

More info
X
Indication:

Traditionally used in Western herbal medicine to decrease/reduce/relieve mild joint aches and pains

Generic Name: Relispray

Strength:95mg

Dosage:

Shelflife Months: 36 M

Pack Size: 1

Tablet Description:

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:

Storage Conditions:

Active Ingredients: camphor 100mg/g, Clove Leaf Oil 10 mg/g, Eucalyptus Oil 60 mg/g, menthol 40 mg/g, turpentine oil 100 mg/g, wintergreen oil 200 mg/g

Warnings:If symptoms persist consult your healthcare practitioner (or words to that effect). Keep out of reach of children (or words to that effect).

X
Indication:

Pharmacor Mycophenolate is indicated for the prophylaxis of solid organ rejection in adults receiving
allogeneic organ transplants.,Pharmacor Mycophenolate is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Generic Name: Mycophenolate mofetil

Strength:1g/5ml

Dosage:

Shelflife Months: 24

Pack Size: 1

Tablet Description:

Segment :A

Innovator:

PBSListed:Yes

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: mycophenolate mofetil 200mg/ml

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-02212-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-CMI-02209-1

X
Indication:

For the prevention of travel sickness

Generic Name: Travel-Ease

Strength:0.3mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pink colored, biplanar, round shaped, beveled edges uncoated tablets with break line on one side and plain on other side.

Segment :A

Innovator:

PBSListed:No

RPBSlisted:

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hyoscine hydrobromide 0.3mg

More info
X
Indication:

TRUST DIFENAC RAPID diclofenac potassium 25 mg tablets are used in short-term treatment (up to one week) for the relief of acute pain states in which there is an inflammatory component. Treatment of acute migraine attacks (with or without aura). Symptomatic treatment of primary dysmenorrhoea.

Generic Name: Difenac Rapid

Strength:25mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:Pink coloured, circular, biconvex, film coated tablets, plain on both sides

Segment :A

Innovator:Voltaren Rapid®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: diclofenac potassium 25mg

Warnings:Protect from Heat